Literature DB >> 393992

The biochemistry and in vitro activity of soluble factors of activated lymphocytes.

C Sorg.   

Abstract

Activated lymphocytes release numerous products which are either synthesized de novo or in increased amounts; some of these products play a role in the regulation of the immune response and are designated as mediators of cellular immune reactions or lymphokines. The first lymphokine described was the macrophage migration inhibitory factor (MIF) which has been studied most extensively with regard to its chemical and biological properties. Using sensitive radiolabelling techniques and an antiserum against highly purified fractions of MIF we were able to identify several products of activated guinea pig lymphocytes with different molecular weights of 15.000, 30.000, 45.000, 60.000 which all had an isoelectric point of 5.2 and were all inhibitory to macrophage migration. It is suggested, that these molecules are oligomers of a common subunit of molecular weight 15.000. It was further shown, that molecules of the same physical-chemical and serological characteristics are produced by activated B-cells, L2C leukemia cells and growing fibroblasts, thus further substantiating earlier reports on the production of MIF by lymphoid and non-lymphoid cells. The described molecules were also shown not to contain determinants of the major histocompatibility complex and to be distinct from lymphotoxin, another lymphocyte activation product. It is concluded, that MIF is not a single molecule but rather a system of structurally related molecules. Their interaction with macrophages and possible relationships to macrophage activating factor is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393992     DOI: 10.1007/bf00223364

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  94 in total

1.  Demonstration of delayed (tuberculin) type hypersensitivity in vitro. I. Selection of methods.

Authors:  J SVEJCAR; J JOHANOVSKY
Journal:  Z Immun exp ther       Date:  1961-12

2.  Protease activity as a possible mechanism of migration inhibitory factor.

Authors:  K Havemann; M Horvat; C P Sodomann; S Bürger
Journal:  Eur J Immunol       Date:  1972-02       Impact factor: 5.532

3.  Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.

Authors:  M K Gately; C L Gately; C S Henney; M M Mayer
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

4.  Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.

Authors:  L P Ruco; M S Meltzer
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

5.  Cell surface receptors for lymphokines. II. Studies on the carbohydrate composition of the MIF receptor on macrophages using synthetic saccharides and plant lectins.

Authors:  G Poste; H Allen; K L Matta
Journal:  Cell Immunol       Date:  1979-04       Impact factor: 4.868

6.  Generation of macrophage migration inhibitory activity by plasminogen activators.

Authors:  R O Roblin; M E Hammond; N D Bensky; A M Dvorak; H F Dvorak; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

7.  Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.

Authors:  K Bendtzen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

8.  Comparsion of the properties of two antigen-induced guinea pig lymphokines.

Authors:  L A Ashworth; B J Eckersley; W H Ford
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

9.  The production of migration inhibition factor by B and T cells of the guinea pig.

Authors:  T Yoshida; H Sonozaki; S Cohen
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.

Authors:  H G Remold
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.